Photo Gallery

Login

Search

News & Updation

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2018 Issue has been successfully launched on 1 November 2018

  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from 6.647 to 7.421 due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  

Abstract

DESIGN AND DEVELOPMENT OF BIOADHESIVEBUCCAL PATCHES OF AN ANTIDIABETIC DRUG

Karishma Nikose*, A. S. Pratapwar, Deepak Joshi and Avinash V. Dhobale

ABSTRACT

The buccal region offers an attractive route of administration for systemic drug delivery. Glimepiride isa potent drug against Diabetes mellitus-II with a half life of 3-5 hours. Though Glimepiride has 100% oral absorption, due to high first pass metabolism its bioavailability is less. The recommended dosage is4 mg b.i.d leading to admistration of the drug twice a day. The present study is aimed to design sustained release mucoadhesivebuccal patch formulation of Glimepiride in order to by-pass GIT and release the drug for extended periods of time. Buccal patches were formulated using polymers Carbopol 934 P(CP 934 P), polyvinyl alcohol and Hydroxy Propyl Methyl Cellulose E 15 (HPMC E 15) in various proportions and combinations. The patches were prepared by solvent casting method. The designed patches were evaluated for thickness uniformity, folding endurance, weight uniformity, content uniformity, swelling behaviour, determination of mucoadhesive time and buccal mucosa sensitivity test. In vitro diffusion studies were conducted for 6 hours in phosphate buffer (pH 6.8) solution using dialysis membrane. Formulation containing maximum amount of swellable and hydrophilic polymer HPMC E 15 and CP 934 P, showed higher swelling index. This occurred due to more hydrophilic polymeric matrix composition which retarded the release of the drug. The diffusion followed zero order kinetic model (R2 = 0.9995).

Keywords: Glimepiride, Buccal, Carbopol, HPMC E 15, Diabetes.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More